Free Trial
OTCMKTS:CVSI

CV Sciences (CVSI) Stock Price, News & Analysis

CV Sciences logo
$0.04 +0.00 (+3.95%)
As of 08/22/2025 03:46 PM Eastern

About CV Sciences Stock (OTCMKTS:CVSI)

Key Stats

Today's Range
$0.04
$0.04
50-Day Range
$0.03
$0.04
52-Week Range
$0.02
$0.05
Volume
30,120 shs
Average Volume
167,340 shs
Market Capitalization
$7.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CV Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

CVSI MarketRank™: 

CV Sciences scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CV Sciences.

  • Price to Book Value per Share Ratio

    CV Sciences has a P/B Ratio of 3.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.00% of the float of CV Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    CV Sciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CV Sciences has recently increased by 6.25%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    CV Sciences does not currently pay a dividend.

  • Dividend Growth

    CV Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the float of CV Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    CV Sciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CV Sciences has recently increased by 6.25%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    CV Sciences has a news sentiment score of 1.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for CV Sciences this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for CVSI on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added CV Sciences to their MarketBeat watchlist in the last 30 days.
Receive CVSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CV Sciences and its competitors with MarketBeat's FREE daily newsletter.

CVSI Stock News Headlines

CV Sciences, Inc. (CVSI) Q2 2025 Earnings Call Transcript
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.tc pixel
Q1 2025 CV Sciences Inc Earnings Call
See More Headlines

CVSI Stock Analysis - Frequently Asked Questions

CV Sciences' stock was trading at $0.0338 at the beginning of 2025. Since then, CVSI stock has increased by 16.9% and is now trading at $0.0395.

CV Sciences, Inc. (OTCMKTS:CVSI) posted its quarterly earnings results on Thursday, August, 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.03). The company earned $5.13 million during the quarter, compared to analyst estimates of $5.12 million. CV Sciences had a negative trailing twelve-month return on equity of 80.82% and a negative net margin of 10.36%.

Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CV Sciences investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Charlotte's Web (CWBHF), Cronos Group (CRON), KUSHCO (KSHB), NVIDIA (NVDA) and Organigram Global (OGI).

Company Calendar

Last Earnings
8/12/2021
Today
8/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CVSI
Previous Symbol
NASDAQ:CVSI
CIK
1510964
Employees
70
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.39 million
Net Margins
-10.36%
Pretax Margin
-10.41%
Return on Equity
-80.82%
Return on Assets
-19.38%

Debt

Debt-to-Equity Ratio
0.12
Current Ratio
1.04
Quick Ratio
0.30

Sales & Book Value

Annual Sales
$15.70 million
Price / Sales
0.46
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.01 per share
Price / Book
3.95

Miscellaneous

Outstanding Shares
184,790,000
Free Float
177,772,000
Market Cap
$7.30 million
Optionable
Not Optionable
Beta
0.61

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:CVSI) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners